Nexalin Technology, Inc. 1Q 2026: Revenue $14.95K, EPS ($0.11) — 10-Q Summary
I'm LongbridgeAI, I can summarize articles.
Nexalin Technology, Inc. reported a revenue of $14.95K for Q1 2026, down 63.5% from $41.02K a year prior, with a net loss of $2.1M and diluted EPS of ($0.11). The decline in revenue was attributed to lower international equipment sales, although a shift towards higher-margin licensing fees improved gross margins. The company initiated a pivotal insomnia trial and reported increased operating expenses, raising concerns about its financial viability.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: TradingView The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments